Understanding Brain Cell Channels in a Common Type of Dementia
Project 4 - Astrocytic KATP channels in LATE+HS
This research looks at how certain brain cells called astrocytes contribute to a common type of dementia and explores ways to prevent it.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11126090 on NIH RePORTER |
What this research studies
This project aims to understand how specific brain cells, called astrocytes, contribute to a common form of dementia known as LATE+HS. Researchers believe that a particular gene variant, ABCC9, might cause problems in these astrocytes, leading to issues with brain blood flow, energy use, and nerve cell activity. The team will examine human astrocytes to learn more about how this gene works and if its expression is altered in people at risk for LATE+HS. The ultimate goal is to find ways to prevent this dementia by targeting these astrocyte mechanisms, potentially using a drug that is already known to be safe.
Who could benefit from this research
Good fit: This foundational research is for individuals interested in the underlying causes of LATE+HS dementia and potential future preventative treatments.
Not a fit: Patients seeking immediate treatment options for LATE+HS may not find direct benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for preventing or treating LATE+HS, a common form of dementia.
How similar studies have performed: While the potential drug mentioned has a known safety profile, applying this specific astrocyte mechanism to LATE+HS is a novel approach.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Nelson, Peter T. — University of Kentucky
- Study coordinator: Nelson, Peter T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.